Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group.
CPT Pharmacometrics Syst Pharmacol
; 10(8): 799-803, 2021 08.
Article
em En
| MEDLINE
| ID: mdl-34247450
ABSTRACT
Quality functions from pharmaceutical sponsor companies aim to increase the use of analytics in their oversight of Good Clinical Practices and Pharmacovigilance activities. To leverage and accelerate progress, several companies decided to establish a collaborative model. The goals of this collaboration span the sharing of knowledge and ideas, the sharing of analytics methods, discussion of talent upskilling and technology adoption strategies, and collaborative discussion on these potential changes with global Health Authorities.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Comportamento Cooperativo
/
Indústria Farmacêutica
/
Desenvolvimento de Medicamentos
Tipo de estudo:
Prognostic_studies
/
Sysrev_observational_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article